EDAP Dec 2024 5.000 call
| Previous close | 1.2000 |
| Open | 1.2000 |
| Bid | 0.0000 |
| Ask | 1.5500 |
| Strike | 5.00 |
| Expiry date | 2024-12-20 |
| Day's range | 1.2000 - 1.2000 |
| Contract range | N/A |
| Volume | |
| Open interest | 576 |
GlobeNewswireEDAP Appoints New Executive Leaders to Strengthen Europe and Middle East Commercial Operations
New appointments bring significant commercial experience with a focus on growing key strategic markets Expands executive leadership in growing disruptive, robotics-based capital equipment in both Urology and Gynecology therapeutic applications LYON, France, June 3, 2024 - EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, today announced the appointments of Damien Desmedt and Alexander Fromm to further strengthen the Company’s European and Middle Eastern commercial
- GlobeNewswire
EDAP to Present at the Jefferies Global Healthcare Conference
LYON, France, May 22, 2024 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that Ryan Rhodes, Chief Executive Officer, is scheduled to deliver a presentation and host 1x1 investor meetings at the Jefferies Global Healthcare Conference, which is being held June 5-6, 2024, in New York City. Presentation details: Date:Wednesday, June 5thTime:7:30 AM ET Webcast:https://wsw.com/webcast/jeff302/edap/1814176 The live and archived webcas
- GlobeNewswire
EDAP Reports First Quarter 2024 Financial Results
Strong Q1 2024 U.S. Focal One® HIFU procedure growth of +92% year-over-year Q1 2024 HIFU revenue of EUR 5.8 million ($6.3 million USD), an increase of 10.2% over Q1 2023Q1 2024 total revenue of EUR 14.9 million ($16.1 million USD) increased 0.8% over Q1 2023Company to host conference call and webcast today, May 16th, at 8:30 a.m. EDT LYON, France, May 16, 2024 - EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, reported today unaudited financial results for the fir
